Last reviewed · How we verify

NCT07405008

Laser Acupuncture on Carpal Tunnel Syndrome .

Not yet recruiting NA Last updated 12 February 2026
What this trial tests

NA trial testing LASER acupuncture technique in Carpal Tunnel Syndrome (CTS) in Breast Cancer Patients in 54 participants. Not yet recruiting.

Timeline
1 March 2026
Primary endpoint
1 May 2026
1 July 2026

Quick facts

Lead sponsorCairo University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment54
Start date1 March 2026
Primary completion1 May 2026
Estimated completion1 July 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 40 to 60, female only, with Carpal Tunnel Syndrome (CTS) in Breast Cancer Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will be carried out on a total number of fifty-four females with age ranged 40 - 60 years old suffering from CTS post mastectomy ,the patients will be randomly assigned into two groups equal in number (27 patients for each group from Damanhur Medical National institute). 1. -Group (A): This group will include 27 patients will receive laser acupuncture technique 3 times per week in addition to traditional physical therapy program (myofascial release, nerve flossing ex., Tendon gliding ex. strengthening ex., ROM ex. and night splint) for 8 weeks. 2. -Group (B): This group will include 27 patients will receive traditional physical therapy program (myofascial release, nerve flossing ex., Tendon gliding ex., strengthening ex., ROM ex. and night splint) for 8 weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07405008.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing